AMWatch

Lundbeckfonden Emerge finder ny partner fra Merck Ventures

Lundbeckfondens ventureenhed med fokus på tidlige biotekinvesteringer har ansat ny partner.

Andreas Jurgeit. | Photo: Lundbeckfonden

37-årige Andreas Jurgeit skifter til en stilling som partner i Lundbeckfonden Emerge, der er den danske fonds investeringsarm med fokus på tidlige investeringer i biotekselskaber.

Han kommer fra en stilling som direktør for life science-gruppen hos Merck Ventures, hvor han har stået for globale investeringer - med porteføljevirksomheder og bestyrelsesmandater i Europa, USA og Israel, skriver Lundbeckfonden Emerge i en pressemeddelelse.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from AMWatch

Savills IM working hard on first Nordic residential investment

The global property investor has plans to expand its growing portfolio in Denmark with a new asset class, residential real estate, "very soon," says Head of Nordics Peter Broström. The manager still believes in the office and retail sectors, despite the pandemic and rising inflation.

Related articles

Latest news

Jobs

Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch